Inés Santisteban

1.5k total citations
38 papers, 1000 citations indexed

About

Inés Santisteban is a scholar working on Molecular Biology, Epidemiology and Immunology. According to data from OpenAlex, Inés Santisteban has authored 38 papers receiving a total of 1000 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 19 papers in Epidemiology and 17 papers in Immunology. Recurrent topics in Inés Santisteban's work include Cytomegalovirus and herpesvirus research (19 papers), Immunodeficiency and Autoimmune Disorders (17 papers) and Virus-based gene therapy research (11 papers). Inés Santisteban is often cited by papers focused on Cytomegalovirus and herpesvirus research (19 papers), Immunodeficiency and Autoimmune Disorders (17 papers) and Virus-based gene therapy research (11 papers). Inés Santisteban collaborates with scholars based in United States, United Kingdom and Türkiye. Inés Santisteban's co-authors include Michael S. Hershfield, Francisco X. Arredondo-Vega, F X Arredondo-Vega, Susan J. Kelly, Sue Povey, Howard M. Lederman, Elizabeth A. Shephard, Ian Phillips, S Kelly and Eva Richard and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Inés Santisteban

37 papers receiving 976 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Inés Santisteban United States 17 378 347 342 314 221 38 1000
N Livni Israel 16 242 0.6× 213 0.6× 54 0.2× 143 0.5× 143 0.6× 42 1.0k
Nobuya Yoshida United States 22 301 0.8× 117 0.3× 964 2.8× 67 0.2× 204 0.9× 38 1.4k
Minh Diem Vu United States 17 261 0.7× 52 0.1× 848 2.5× 93 0.3× 295 1.3× 26 1.4k
Ilana Chefetz United States 19 420 1.1× 184 0.5× 367 1.1× 71 0.2× 163 0.7× 30 1.6k
Anne‐Laure Mathieu France 15 322 0.9× 59 0.2× 444 1.3× 49 0.2× 134 0.6× 39 901
Susan B. Liu United States 9 339 0.9× 48 0.1× 124 0.4× 384 1.2× 138 0.6× 9 971
Lyle E. Pegg United States 11 431 1.1× 103 0.3× 217 0.6× 39 0.1× 162 0.7× 17 873
M Giralt Spain 19 522 1.4× 59 0.2× 198 0.6× 329 1.0× 96 0.4× 50 1.7k
Abdelaziz Gdoura France 8 253 0.7× 28 0.1× 361 1.1× 114 0.4× 178 0.8× 11 740
Justin A. Shyer United States 10 419 1.1× 97 0.3× 814 2.4× 90 0.3× 312 1.4× 16 1.3k

Countries citing papers authored by Inés Santisteban

Since Specialization
Citations

This map shows the geographic impact of Inés Santisteban's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inés Santisteban with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inés Santisteban more than expected).

Fields of papers citing papers by Inés Santisteban

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inés Santisteban. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inés Santisteban. The network helps show where Inés Santisteban may publish in the future.

Co-authorship network of co-authors of Inés Santisteban

This figure shows the co-authorship network connecting the top 25 collaborators of Inés Santisteban. A scholar is included among the top collaborators of Inés Santisteban based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inés Santisteban. Inés Santisteban is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Santisteban, Inés, et al.. (2024). Evolving spectrum of adenosine deaminase (ADA) deficiency: Assessing genotype pathogenicity according to expressed ADA activity of 46 variants. Journal of Allergy and Clinical Immunology. 155(1). 166–175.
2.
Çağdaş, Deniz, Pınar Gür Çetinkaya, Betül Karaatmaca, et al.. (2018). ADA Deficiency: Evaluation of the Clinical and Laboratory Features and the Outcome. Journal of Clinical Immunology. 38(4). 484–493. 22 indexed citations
3.
Genel, Ferah, et al.. (2015). Adenosine Deaminase-Deficient Severe Combined Immunodeficiency and Diffuse Large B-Cell Lymphoma. Pediatric Allergy Immunology and Pulmonology. 28(2). 138–142. 4 indexed citations
4.
Notarangelo, Lucia Dora, Luisa Imberti, Michael S. Hershfield, et al.. (2015). Diagnosis, Treatment and Long-Term Follow Up of Patients with ADA Deficiency: a Single-Center Experience. Journal of Clinical Immunology. 35(7). 624–637. 17 indexed citations
5.
Moncada‐Vélez, Marcela, A. Catalina Vélez-Ortega, Julio César Orrego, et al.. (2011). Somatic Mosaicism Caused by Monoallelic Reversion of a Mutation in T Cells of a Patient with ADA‐SCID and the Effects of Enzyme Replacement Therapy on the Revertant Phenotype. Scandinavian Journal of Immunology. 74(5). 471–481. 12 indexed citations
6.
Hershfield, Michael S., L. Jackson Roberts, Nancy J. Ganson, et al.. (2010). Treating gout with pegloticase, a PEGylated urate oxidase, provides insight into the importance of uric acid as an antioxidant in vivo. Proceedings of the National Academy of Sciences. 107(32). 14351–14356. 104 indexed citations
7.
Aytekin, Caner, Figen Doğu, Gönül Tanır, et al.. (2009). Purine nucleoside phosphorylase deficiency with fatal course in two sisters. European Journal of Pediatrics. 169(3). 311–314. 14 indexed citations
8.
Artaç, Hasibe, Şefika Elmas Bozdemir, Hatice Toy, et al.. (2009). Late-onset adenosine deaminase deficiency presenting with Heck’s disease. European Journal of Pediatrics. 169(8). 1033–1036. 13 indexed citations
9.
Santisteban, Inés, et al.. (2003). E. coli Expression System for Identifying Folding Mutations of Human Adenosine Deaminase. Humana Press eBooks. 232. 175–182. 1 indexed citations
10.
Richard, Eva, Francisco X. Arredondo-Vega, Inés Santisteban, et al.. (2000). The Binding Site of Human Adenosine Deaminase for Cd26/Dipeptidyl Peptidase IV. The Journal of Experimental Medicine. 192(9). 1223–1236. 54 indexed citations
11.
Arredondo-Vega, Francisco X., et al.. (1998). Adenosine Deaminase Deficiency: Genotype-Phenotype Correlations Based on Expressed Activity of 29 Mutant Alleles. The American Journal of Human Genetics. 63(4). 1049–1059. 83 indexed citations
12.
Bollinger, Mary E., Francisco X. Arredondo-Vega, Inés Santisteban, et al.. (1996). Hepatic Dysfunction as a Complication of Adenosine Deaminase Deficiency. New England Journal of Medicine. 334(21). 1367–1372. 77 indexed citations
13.
Santisteban, Inés, F X Arredondo-Vega, S Kelly, et al.. (1995). Three new adenosine deaminase mutations that define a splicing enhancer and cause severe and partial phenotypes: implications for evolution of a CpG hotspot and expression of a transduced ADA cDNA. Human Molecular Genetics. 4(11). 2081–2087. 45 indexed citations
14.
Arredondo-Vega, F X, et al.. (1994). Correct splicing despite mutation of the invariant first nucleotide of a 5' splice site: a possible basis for disparate clinical phenotypes in siblings with adenosine deaminase deficiency.. PubMed. 54(5). 820–30. 36 indexed citations
15.
Arredondo-Vega, F X, et al.. (1990). Paradoxical expression of adenosine deaminase in T cells cultured from a patient with adenosine deaminase deficiency and combine immunodeficiency.. Journal of Clinical Investigation. 86(2). 444–452. 27 indexed citations
16.
Shephard, Elizabeth A., Ian Phillips, Inés Santisteban, et al.. (1989). Isolation of a human cytochrome P‐450 reductase cDNA clone and localization of the corresponding gene to chromosome 7q11.2. Annals of Human Genetics. 53(4). 291–301. 32 indexed citations
17.
Bull, Peter C., et al.. (1989). Isolation and characterization of genes coding for cytochrome b5 and cytochrome- b5 reductase. Biochemical Society Transactions. 17(1). 194–195. 6 indexed citations
18.
Santisteban, Inés, Sue Povey, Elizabeth A. Shephard, & Ian Phillips. (1988). The major phenobarbital‐inducible cytochrome P‐450 gene subfamily (P450IIB) mapped to the long arm of human chromosome 19. Annals of Human Genetics. 52(2). 129–135. 24 indexed citations
19.
Bull, Peter C., Elizabeth A. Shephard, Sue Povey, Inés Santisteban, & Ian Phillips. (1988). Cloning and chromosomal mapping of human cytochrome b5 reductase (DIA1). Annals of Human Genetics. 52(4). 263–268. 16 indexed citations
20.
Santisteban, Inés, Sue Povey, L. F. WEST, J M Parrington, & D. A. HOPKINSON. (1985). Chromosome assignment, biochemical and immunological studies on a human aldehyde dehydrogenase, ALDH3. Annals of Human Genetics. 49(2). 87–100. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026